Table 1.
CAA, n=42 | AD/MCI, n=43 | Healthy Elderly, n=50 | |
---|---|---|---|
Age, mean (±SD) | 68 (10) | 74 (7.4) | 73.3 (7) |
Female % | 26 | 40 | 58 |
Hypertension % | 57 | 67 | 28 |
Diabetes Mellitus % | 10 | 14 | 0 |
Hyperlipidemia % | 38 | 74 | 14 |
ApoE ε2, % allele frequency * | 13 | 0 | 9 |
ApoE ε4, % allele frequency * | 37 | 32 | 8 |
Global DVR, mean (±SD) | 1.33 (0.2) | 1.33 (0.27) | 1.17 (0.13) |
Lobar CMB count, median (IQR) | 25 (5–57) | none | none |
WMH volume in ml, median (IQR) | 21 (9.9–32) | 10.8 (5–16.3) | 3.2 (2–5.6) |
WMH percent of ICV, median (IQR) | 1.2 (0.6–1.9) | 0.68 (0.3–0.9) | 0.2 (0.1–0.4) |
APOE genotype was available in all CAA patients, 33 HE and 11 AD/MCI cases.
DVR = distribution volume ratio
CMB = cerebral microbleed
WMH = white matter hyperintensities
ICV = intracranial volume